Marshall Wace’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100
Closed -$7.9K 3252
2025
Q4
$7.9K Buy
+100
New +$7.84K ﹤0.01% 2871
2024
Q1
Sell
-89,700
Closed -$7.15M 2478
2023
Q4
$7.15M Buy
+89,700
New +$6.74M 0.01% 783

Other funds holding CL

Marshall Wace's CL Position: Q2 2026 in Review

Marshall Wace increased its Colgate-Palmolive (CL) stake by 3,994% in Q2 2026, buying an estimated $14M and bringing the position to 163,762 shares worth $15M. The position accounts for 0.01% of the portfolio, ranked #853.

Marshall Wace first reported a position in CL in Q1 2014 and has held it in 39 quarters since. The position peaked at $164M in Q4 2023. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Marshall Wace held 163,762 shares of Colgate-Palmolive worth $15M as of Q2 2026.
  • Marshall Wace bought 159,762 Colgate-Palmolive shares in Q2 2026, an estimated $14M.
  • Colgate-Palmolive made up 0.01% of Marshall Wace's portfolio in Q2 2026, its #853 holding.
  • Marshall Wace first reported a position in Colgate-Palmolive in Q1 2014 and has held it in 39 quarters since.
  • Marshall Wace's Colgate-Palmolive position peaked at $164M in Q4 2023.
  • 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.